Bernie Huyghe, PhD

Bernie Huyghe Chief Technology Officer | Bernie has over 30 years of biologics CMC development, technology transfers, scale-up and manufacture for recombinant proteins, cell, and gene therapies.  Before joining Candid, Bernie previously held positions at Viridian Therapeutics, Allogene, Pfizer, CovX , Chugai, Schering-Plough and Canji among others. Bernie holds a Bachelor of Science in Chemistry from the University of Florida and a Ph.D. in Biophysical Chemistry from The University of California, Berkeley.